A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin

AIMS: To investigate the efficacy, safety and tolerability of sitagliptin 50 mg once daily added to ipragliflozin 50 mg once daily monotherapy in Japanese patients with type 2 diabetes (T2D). MATERIALS AND METHODS: Japanese patients with T2D and glycated haemoglobin (HbA1c) 7.0% to 10.0% while treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Seino, Yutaka, Kaku, Kohei, Kadowaki, Takashi, Okamoto, Taro, Sato, Asako, Shirakawa, Masayoshi, O'Neill, Edward A., Engel, Samuel S., Kaufman, Keith D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2021
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248366/
https://ncbi.nlm.nih.gov/pubmed/33565686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14346
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge